Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 2/2010

01-04-2010 | Review Article

Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis

Authors: Yasushi Toh, Eiji Oki, Kippei Ohgaki, Yasuo Sakamoto, Shuhei Ito, Akinori Egashira, Hiroshi Saeki, Yoshihiro Kakeji, Masaru Morita, Yoshihisa Sakaguchi, Takeshi Okamura, Yoshihiko Maehara

Published in: International Journal of Clinical Oncology | Issue 2/2010

Login to get access

Abstract

Esophageal cancer is the eighth most common incident cancer in the world and ranks sixth among all cancers in mortality. Esophageal cancers are classified into two histological types; esophageal squamous cell carcinoma (ESCC), and adenocarcinoma, and the incidences of these types show a striking variety of geographic distribution, possibly reflecting differences in exposure to specific environmental factors. Both alcohol consumption and cigarette smoking are major risk factors for the development of ESCC. Acetaldehyde is the most toxic ethanol metabolite in alcohol-associated carcinogenesis, while ethanol itself stimulates carcinogenesis by inhibiting DNA methylation and by interacting with retinoid metabolism. Cigarette smoke contains more than 60 carcinogens and there are strong links between some of these carcinogens and various smoking-induced cancers; these mechanisms are well established. Synergistic effects of cigarette smoking and alcohol consumption are also observed in carcinogenesis of the upper aerodigestive tract. Of note, intensive molecular biological studies have revealed the molecular mechanisms involved in the development of ESCC, including genetic and epigenetic alterations. However, a wide range of molecular changes is associated with ESCC, possibly because the esophagus is exposed to many kinds of carcinogens including alcohol and cigarette smoke, and it remains unclear which alterations are the most critical for esophageal carcinogenesis. This brief review summarizes the general mechanisms of alcohol- and smoking-induced carcinogenesis and then discusses the mechanisms of the development of ESCC, with special attention to alcohol consumption and cigarette smoking.
Literature
1.
Baan R, Straif K, Grosse Y et al (2007) Carcinogenicity of alcoholic beverages. Lancet Oncol 8:292–293PubMed
2.
The International Agency for Research on Cancer (1988) Alcohol drinking. IARC, Lyon
3.
Seitz HK, Stickel F (2007) Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 7:599–612PubMed
4.
The International Agency for Research on Cancer (2004) Tobacco smoke and involuntary smoking. IARC, Lyon, pp 53–119
5.
Hecht SS (2006) Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbecks Arch Surg 391:603–613PubMed
6.
The International Agency for Research on Cancer (2004) Tobacco smoke and involuntary smoking. IARC, Lyon, pp 1179–1187
7.
Xu XC (2009) Risk factors and gene expression in esophageal cancer. Methods Mol Biol 471:335–360PubMed
8.
Mandard AM, Hainaut P, Hollstein M (2000) Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res 462:335–342PubMed
9.
Stoner GD, Gupta A (2001) Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 22:1737–1746PubMed
10.
Metzger R, Schneider PM, Warnecke-Eberz U et al (2004) Molecular biology of esophageal cancer. Onkologie 27:200–206PubMed
11.
Kuwano H, Kato H, Miyazaki T et al (2005) Genetic alterations in esophageal cancer. Surg Today 35:7–18PubMed
12.
Wang XD (2005) Alcohol, vitamin A, and cancer. Alcohol 35:251–258PubMed
13.
Yokoyama A, Kato H, Yokoyama T et al (2002) Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma. Carcinogenesis 23:1851–1859PubMed
14.
Yokoyama A, Omori T, Yokoyama T (2007) Risk appraisal and endoscopic screening for esophageal squamous cell carcinoma in Japanese populations. Esophagus 4:135–143
15.
Homann N, Tillonen J, Meurman JH et al (2000) Increased salivary acetaldehyde levels in heavy drinkers and smokers: a microbiological approach to oral cavity cancer. Carcinogenesis 21:663–668PubMed
16.
Bartsch H (1996) DNA adducts in human carcinogenesis: etiological relevance and structure–activity relationship. Mutat Res 340:67–79PubMed
17.
Matsuda T, Kawanishi M, Yagi T et al (1998) Specific tandem GG to TT base substitutions induced by acetaldehyde are due to intra-strand crosslinks between adjacent guanine bases. Nucleic Acids Res 26:1769–1774PubMed
18.
Maffei F, Fimognari C, Castelli E et al (2000) Increased cytogenetic damage detected by FISH analysis on micronuclei in peripheral lymphocytes from alcoholics. Mutagenesis 15:517–523PubMed
19.
Fang JL, Vaca CE (1997) Detection of DNA adducts of acetaldehyde in peripheral white blood cells of alcohol abusers. Carcinogenesis 18:627–632PubMed
20.
Theruvathu JA, Jaruga P, Nath RG et al (2005) Polyamines stimulate the formation of mutagenic 1, N2-propanodeoxyguanosine adducts from acetaldehyde. Nucleic Acids Res 33:3513–3520PubMed
21.
Simanowski UA, Suter P, Stickel F et al (1993) Esophageal epithelial hyperproliferation following long-term alcohol consumption in rats: effects of age and salivary gland function. J Natl Cancer Inst 85:2030–2033PubMed
22.
Homann N, Karkkainen P, Koivisto T et al (1997) Effects of acetaldehyde on cell regeneration and differentiation of the upper gastrointestinal tract mucosa. J Natl Cancer Inst 89:1692–1697PubMed
23.
Garro AJ, Espina N, Farinati F et al (1986) The effects of chronic ethanol consumption on carcinogen metabolism and on O6-methylguanine transferase-mediated repair of alkylated DNA. Alcohol Clin Exp Res 10:73S–77SPubMed
24.
Homann N, Seitz HK, Wang XD et al (2005) Mechanisms in alcohol-associated carcinogenesis. Alcohol Clin Exp Res 29:1317–1320PubMed
25.
Seitz HK, Stickel F (2006) Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol Chem 387:349–360PubMed
26.
Shimizu M, Lasker JM, Tsutsumi M et al (1990) Immunohistochemical localization of ethanol-inducible P450IIE1 in the rat alimentary tract. Gastroenterology 99:1044–1053PubMed
27.
Chamulitrat W, Spitzer JJ (1996) Nitric oxide and liver injury in alcohol-fed rats after lipopolysaccharide administration. Alcohol Clin Exp Res 20:1065–1070PubMed
28.
Hu W, Feng Z, Eveleigh J et al (2002) The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. Carcinogenesis 23:1781–1789PubMed
29.
Mena S, Ortega A, Estrela JM (2009) Oxidative stress in environmental-induced carcinogenesis. Mutat Res 674:36–44PubMed
30.
Baylin SB (2005) DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2(Suppl 1):S4–S11PubMed
31.
Martinez-Chantar ML, Garcia-Trevijano ER, Latasa MU et al (2002) Importance of a deficiency in S-adenosyl-l-methionine synthesis in the pathogenesis of liver injury. Am J Clin Nutr 76:1177S–1182SPubMed
32.
Choi SW, Stickel F, Baik HW et al (1999) Chronic alcohol consumption induces genomic but not p53-specific DNA hypomethylation in rat colon. J Nutr 129:1945–1950PubMed
33.
Liu C, Russell RM, Seitz HK et al (2001) Ethanol enhances retinoic acid metabolism into polar metabolites in rat liver via induction of cytochrome P4502E1. Gastroenterology 120:179–189PubMed
34.
Wang XD, Liu C, Chung J et al (1998) Chronic alcohol intake reduces retinoic acid concentration and enhances AP-1 (c-Jun and c-Fos) expression in rat liver. Hepatology 28:744–750PubMed
35.
Pfeifer GP, Denissenko MF, Olivier M et al (2002) Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21:7435–7451PubMed
36.
Straif K, Baan R, Grosse Y et al (2005) Carcinogenicity of polycyclic aromatic hydrocarbons. Lancet Oncol 6:931–932PubMed
37.
Kamangar F, Chow WH, Abnet CC et al (2009) Environmental causes of esophageal cancer. Gastroenterol Clin North Am 38:27–57PubMed
38.
Hecht SS (1998) Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 11:559–603PubMed
39.
Hecht SS, Hoffmann D (1989) The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv 8:273–294PubMed
40.
Lijinsky W (1992) Chemistry and biology of N-nitroso compounds. Cambridge University Press, Cambridge
41.
Arora A, Willhite CA, Liebler DC (2001) Interactions of beta-carotene and cigarette smoke in human bronchial epithelial cells. Carcinogenesis 22:1173–1178PubMed
42.
Hecht SS (1999) Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91:1194–1210PubMed
43.
Guengerich FP (2001) Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol 14:611–650PubMed
44.
Jalas JR, Hecht SS, Murphy SE (2005) Cytochrome P450 enzymes as catalysts of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco specific carcinogen. Chem Res Toxicol 18:95–110PubMed
45.
Tang D, Phillips DH, Stampfer M et al (2001) Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Cancer Res 61:6708–6712PubMed
46.
Armstrong R (1997) Glutathione S-transferases. In: Guengerich F (ed) Comprehensive toxicology: biotransformation. Elsevier, New York, pp 307–327
47.
Burchell B, McGurk K, Brierley CH et al (1997) UDP-glucuronosyltransferases. In: Guengerich FP (eds) Comprehensive toxicology: biotransformation, vol 3. Elsevier Science, New York, pp 401–436
48.
Hoeijmakers JH (2001) Genome maintenance mechanisms for preventing cancer. Nature 411:366–374PubMed
49.
Bode AM, Dong Z (2005) Signal transduction pathways in cancer development and as targets for cancer prevention. Prog Nucleic Acid Res Mol Biol 79:237–297PubMed
50.
Liu Z, Muehlbauer KR, Schmeiser HH et al (2005) p53 mutations in benzo(a)pyrene-exposed human p53 knock-in murine fibroblasts correlate with p53 mutations in human lung tumors. Cancer Res 65:2583–2587PubMed
51.
Pfeifer GP, Besaratinia A (2009) Mutational spectra of human cancer. Hum Genet 125:493–506PubMed
52.
Kozack R, Seo KY, Jelinsky SA et al (2000) Toward an understanding of the role of DNA adduct conformation in defining mutagenic mechanism based on studies of the major adduct (formed at N(2)-dG) of the potent environmental carcinogen, benzo[a]pyrene. Mutat Res 450:41–59PubMed
53.
Denissenko MF, Pao A, Tang M et al (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274:430–432PubMed
54.
Ye YN, Liu ES, Shin VY et al (2004) Nicotine promoted colon cancer growth via epidermal growth factor receptor, c-Src, and 5-lipoxygenase-mediated signal pathway. J Pharmacol Exp Ther 308:66–72PubMed
55.
Zong Y, Zhang ST, Zhu ST (2009) Nicotine enhances migration and invasion of human esophageal squamous carcinoma cells which is inhibited by nimesulide. World J Gastroenterol 15:2500–2505PubMed
56.
Heeschen C, Jang JJ, Weis M et al (2001) Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 7:833–839PubMed
57.
West KA, Brognard J, Clark AS et al (2003) Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 111:81–90PubMed
58.
Moraitis D, Du B, De Lorenzo MS et al (2005) Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands. Cancer Res 65:664–670PubMed
59.
Xu XC (2002) COX-2 inhibitors in cancer treatment and prevention, a recent development. Anticancer Drugs 13:127–137PubMed
60.
Belinsky SA (2005) Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer. Carcinogenesis 26:1481–1487PubMed
61.
Morita M, Saeki H, Mori M et al (2002) Risk factors for esophageal cancer and the multiple occurrence of carcinoma in the upper aerodigestive tract. Surgery 131:S1–S6PubMed
62.
Homann N, Tillonen J, Rintamaki H et al (2001) Poor dental status increases acetaldehyde production from ethanol in saliva: a possible link to increased oral cancer risk among heavy drinkers. Oral Oncol 37:153–158PubMed
63.
Salaspuro V, Salaspuro M (2004) Synergistic effect of alcohol drinking and smoking on in vivo acetaldehyde concentration in saliva. Int J Cancer 111:480–483PubMed
64.
Helander A, Curvall M (1991) Comparison of blood aldehyde dehydrogenase activities in moist snuff users, cigarette smokers and nontobacco users. Alcohol Clin Exp Res 15:1–6PubMed
65.
Salaspuro M (2007) Interrelationship between alcohol, smoking, acetaldehyde and cancer. Novartis Foundation Symposium 285:80–89; discussion 89–96, 198–199
66.
Hollstein M, Sidransky D, Vogelstein B et al (1991) p53 mutations in human cancers. Science 253:49–53PubMed
67.
Haupt Y, Maya R, Kazaz A et al (1997) Mdm2 promotes the rapid degradation of p53. Nature 387:296–299PubMed
68.
Lane DP (1992) Cancer. p53, guardian of the genome. Nature 358:15–16PubMed
69.
Parenti AR, Rugge M, Frizzera E et al (1995) p53 overexpression in the multistep process of esophageal carcinogenesis. Am J Surg Pathol 19:1418–1422PubMedCrossRef
70.
Egashira A, Morita M, Kakeji Y et al (2007) p53 gene mutations in esophageal squamous cell carcinoma and their relevance to etiology and pathogenesis: results in Japan and comparisons with other countries. Cancer Sci 98:1152–1156PubMed
71.
Oki E, Zhao Y, Yoshida R et al (2009) The difference in p53 mutations between cancers of the upper and lower gastrointestinal tract. Digestion 79 (Suppl 1):33–39
72.
Paget V, Lechevrel M, Sichel F (2008) Acetaldehyde-induced mutational pattern in the tumour suppressor gene TP53 analysed by use of a functional assay, the FASAY (functional analysis of separated alleles in yeast). Mutat Res 652:12–19PubMed
73.
Noori P, Hou SM (2001) Mutational spectrum induced by acetaldehyde in the HPRT gene of human T lymphocytes resembles that in the p53 gene of esophageal cancers. Carcinogenesis 22:1825–1830PubMed
74.
Bodner SM, Minna JD, Jensen SM et al (1992) Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene 7:743–749PubMed
75.
Saeki H, Ohno S, Araki K et al (2000) Alcohol consumption and cigarette smoking in relation to high frequency of p53 protein accumulation in oesophageal squamous cell carcinoma in the Japanese. Br J Cancer 82:1892–1894PubMed
76.
Kato H, Yoshikawa M, Miyazaki T et al (2001) Expression of p53 protein related to smoking and alcoholic beverage drinking habits in patients with esophageal cancers. Cancer Lett 167:65–72PubMed
77.
Kuwano H, Ohno S, Matsuda H et al (1988) Serial histologic evaluation of multiple primary squamous cell carcinomas of the esophagus. Cancer 61:1635–1638PubMed
78.
Ito S, Ohga T, Saeki H et al (2005) p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis. Int J Cancer 113:22–28PubMed
79.
el-Deiry WS, Harper JW, O’Connor PM et al (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169–1174PubMed
80.
Bahl R, Arora S, Nath N et al (2000) Novel polymorphism in p21(waf1/cip1) cyclin dependent kinase inhibitor gene: association with human esophageal cancer. Oncogene 19:323–328PubMed
81.
Toh Y, Kuwano H, Sonoda K et al (1997) Correlation between reduced p21WAF1/CIP1 expression and abnormal p53 expression in esophageal carcinomas. Int J Oncol 11:703–708
82.
Ruas M, Peters G (1998) The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1378:F115–F177PubMed
83.
Tokugawa T, Sugihara H, Tani T et al (2002) Modes of silencing of p16 in development of esophageal squamous cell carcinoma. Cancer Res 62:4938–4944PubMed
84.
Prueitt RL, Goodman JE, Valberg PA (2009) Radionuclides in cigarettes may lead to carcinogenesis via p16(INK4a) inactivation. J Environ Radioact 100:157–161PubMed
85.
Ito S, Ohga T, Saeki H et al (2007) Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma. Anticancer Res 27:3345–3353PubMed
86.
Esteller M, Cordon-Cardo C, Corn PG et al (2001) p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2. Cancer Res 61:2816–2821PubMed
87.
Baldin V, Lukas J, Marcote MJ et al (1993) Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7:812–821PubMed
88.
Hu H, Zhang S, Zhu S (2009) Influence of aspirin and cigarette smoke extract on the expression of cyclin D1 and effects of cell cycle in esophageal squamous cell carcinoma cell line. Dis Esophagus 22:310–316PubMed
89.
Bizari L, Borim AA, Leite KR et al (2006) Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers. Cancer Genet Cytogenet 165:41–50PubMed
90.
Ozawa S, Ueda M, Ando N et al (1989) Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas. Cancer 63:2169–2173PubMed
91.
Kitagawa Y, Ueda M, Ando N et al (1996) Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2:909–914PubMed
92.
Hanawa M, Suzuki S, Dobashi Y et al (2006) EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus. Int J Cancer 118:1173–1180PubMed
93.
Sudo T, Mimori K, Nagahara H et al (2007) Identification of EGFR mutations in esophageal cancer. Eur J Surg Oncol 33:44–48PubMed
94.
Dragnev KH, Petty WJ, Dmitrovsky E (2003) Retinoid targets in cancer therapy and chemoprevention. Cancer Biol Ther 2:S150–S156PubMed
95.
Lango M, Wentzel AL, Song JI et al (2003) Responsiveness to the retinoic acid receptor-selective retinoid LGD1550 correlates with abrogation of transforming growth factor alpha/epidermal growth factor receptor autocrine signaling in head and neck squamous carcinoma cells. Clin Cancer Res 9:4205–4213PubMed
96.
Wang XD, Liu C, Bronson RT et al (1999) Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst 91:60–66PubMed
97.
Song S, Xu XC (2001) Effect of benzo[a]pyrene diol epoxide on expression of retinoic acid receptor-beta in immortalized esophageal epithelial cells and esophageal cancer cells. Biochem Biophys Res Commun 281:872–877PubMed
98.
Song S, Lippman SM, Zou Y et al (2005) Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expression. Oncogene 24:8268–8276PubMed
99.
Xu XC (2007) Tumor-suppressive activity of retinoic acid receptor-beta in cancer. Cancer Lett 253:14–24PubMed
100.
Zimmermann KC, Sarbia M, Weber AA et al (1999) Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 59:198–204PubMed
101.
Yoshino I, Kometani T, Shoji F et al (2007) Induction of epithelial–mesenchymal transition-related genes by benzo[a]pyrene in lung cancer cells. Cancer 110:369–374PubMed
102.
Yoshino I, Maehara Y (2007) Impact of smoking status on the biological behavior of lung cancer. Surg Today 37:725–734PubMed
103.
Davis R, Rizwani W, Banerjee S et al (2009) Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One 4:e7524PubMed
104.
Mori T, Aoki T, Matsubara T et al (1994) Frequent loss of heterozygosity in the region including BRCA1 on chromosome 17q in squamous cell carcinomas of the esophagus. Cancer Res 54:1638–1640PubMed
105.
Liang Z, Lippman SM, Kawabe A et al (2003) Identification of benzo(a)pyrene diol epoxide-binding DNA fragments using DNA immunoprecipitation technique. Cancer Res 63:1470–1474PubMed
106.
Ohta M, Inoue H, Cotticelli MG et al (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587–597PubMed
107.
Mori M, Mimori K, Shiraishi T et al (2000) Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus. Cancer Res 60:1177–1182PubMed
108.
Tanaka H, Shimada Y, Harada H et al (1998) Methylation of the 5′ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Cancer Res 58:3429–3434PubMed
109.
Pekarsky Y, Zanesi N, Palamarchuk A et al (2002) FHIT: from gene discovery to cancer treatment and prevention. Lancet Oncol 3:748–754PubMed
110.
Soma T, Kaganoi J, Kawabe A et al (2006) Nicotine induces the fragile histidine triad methylation in human esophageal squamous epithelial cells. Int J Cancer 119:1023–1027PubMed
111.
Morita M, Oyama T, Nakata S et al (2006) Expression of FHIT in esophageal epithelium and carcinoma: reference to drinking, smoking and multicentric carcinogenesis. Anticancer Res 26:2243–2248PubMed
112.
Naidoo R, Chetty R (1999) DNA repair gene status in oesophageal cancer. Mol Pathol 52:125–130PubMed
113.
Mimori K, Inoue H, Shiraishi T et al (2003) Microsatellite instability is often observed in esophageal carcinoma patients with allelic loss in the FHIT/FRA3B locus. Oncology 64:275–279PubMed
114.
Kakegawa T (2003) Forty years’ experience in surgical treatment for esophageal cancer. Int J Clin Oncol 8:277–288PubMed
115.
Toh Y, Sakaguchi Y, Ikeda O et al (2009) The triangulating stapling technique for cervical esophagogastric anastomosis after esophagectomy. Surg Today 39:201–206PubMed
116.
Toh Y, Yamamoto M, Endo K et al (2003) Histone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinoma. Oncol Rep 10:333–338PubMed
117.
Toh Y, Ohga T, Endo K et al (2004) Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas. Int J Cancer 110:362–367PubMed
Metadata
Title
Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis
Authors
Yasushi Toh
Eiji Oki
Kippei Ohgaki
Yasuo Sakamoto
Shuhei Ito
Akinori Egashira
Hiroshi Saeki
Yoshihiro Kakeji
Masaru Morita
Yoshihisa Sakaguchi
Takeshi Okamura
Yoshihiko Maehara
Publication date
01-04-2010
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 2/2010
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-010-0057-6

Other articles of this Issue 2/2010

International Journal of Clinical Oncology 2/2010 Go to the issue

Original Article

18F-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer

Case Report

Erythrocytosis caused by erythropoietin-producing thymic carcinoma

Letter to the Editor

Indispensability of UGT1A1*6 genotyping in Japanese cancer patients treated with irinotecan

Case Report

Huge pedunculated angiomyofibroblastoma of the vulva

Review Article

Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention

Case Report

Hepatosplenic αβ T cell lymphoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits